Board Meeting Details

The Board of Directors meeting was held on 12th November 2026, commencing at 4:00 PM and concluding at 6:30 PM.

Key Financial Results (₹ in Lakhs)

Quarterly Performance (Q2 FY27 vs Q2 FY26 vs Q1 FY27)

  • Revenue from operations: ₹2,073.74 (Q2 FY27) vs ₹1,895.92 (Q2 FY25) vs ₹2,237.91 (Q1 FY27)
  • Other Income: ₹40.55 vs ₹55.40 vs ₹44.50
  • Total Income: ₹2,114.29 vs ₹1,951.32 vs ₹2,282.41
  • Profit Before Tax: ₹291.05 vs ₹363.36 vs ₹369.46
  • Current Tax: ₹63.17 vs ₹74.97 vs ₹92.99
  • Profit After Tax: ₹228.33 vs ₹261.91 vs ₹272.30
  • EPS (Basic & Diluted): ₹3.97 vs ₹4.55 vs ₹4.73

Half-Yearly Performance (H1 FY27 vs H1 FY26)

  • Revenue from operations: ₹4,311.65 vs ₹3,758.34
  • Other Income: ₹85.05 vs ₹109.96
  • Total Income: ₹4,396.70 vs ₹3,868.30
  • Profit Before Tax: ₹660.51 vs ₹607.46
  • Current Tax: ₹156.16 vs ₹136.41
  • Profit After Tax: ₹500.63 vs ₹444.57
  • EPS (Basic & Diluted): ₹8.70 vs ₹7.72

Segment Information

The company operates in two business segments:

Pharmaceuticals Segment (H1 FY27)

  • Revenue: ₹4,239.09 lakh (98.3% of total)
  • Segment Profit before tax and interest: ₹617.36 lakh
  • Segment Assets: ₹8,165.21 lakh

Renewable Energy Segment (H1 FY27)

  • Revenue: ₹72.56 lakh (1.7% of total)
  • Segment Profit before tax and interest: ₹47.86 lakh
  • Segment Assets: ₹849.45 lakh

Financial Position (as of 30-09-2026)

  • Total Assets: ₹9,014.66 lakh (vs ₹9,908.51 lakh as of 31-03-2026)
  • Property, Plant and Equipment: ₹1,903.83 lakh
  • Inventories: ₹483.60 lakh
  • Trade Receivables: ₹2,944.59 lakh
  • Cash and Cash Equivalents: ₹2,139.81 lakh
  • Total Equity: ₹7,914.15 lakh
  • Current Liabilities: ₹891.56 lakh
  • Borrowings: ₹2.21 lakh

Cash Flow Statement (H1 FY27)

  • Net Cash from Operating Activities: (₹324.35) lakh
  • Net Cash from Investing Activities: ₹21.38 lakh
  • Net Cash from Financing Activities: (₹492.41) lakh
  • Net Decrease in Cash: (₹795.38) lakh
  • Dividend Paid: ₹287.87 lakh

Audit and Approval

  • The financial results were reviewed by the Audit Committee and approved by the Board of Directors
  • Statutory auditors conducted a limited review and expressed an unmodified review conclusion
  • The results are unaudited but prepared in accordance with Indian Accounting Standard 34 (Ind AS 34)

Capital Structure

  • Paid-up equity share capital: ₹575.73 lakh (Face value of ₹10 each)
  • Number of shares: 575,730 shares (unchanged from previous periods)